Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Cochet

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding SiteBenoît Bestgen, Isabelle Krimm, Irina Kufareva, et al.
The Journal of Biological Chemistry|June 26, 2004
Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporterStein Roosbeek, Frank Peelman, Annick Verhee, et al.
Cancer Research|December 2, 2010
Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2Renaud Prudent, Virginie Moucadel, Chi-Hung Nguyen, et al.
Scientific Reports|November 6, 2019
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitorsIrina Kufareva, Benoit Bestgen, Paul Brear, et al.
Iscience|February 6, 2024
Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocketAlexandre Bancet, Rita Frem, Florian Jeanneret, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Molecular and Cellular Biochemistry|June 20, 2008
Expanding the chemical diversity of CK2 inhibitorsRenaud Prudent, Virginie Moucadel, Miriam López-Ramos, et al.
Journal of Medicinal Chemistry|September 25, 2012
Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine BTania Tahtouh, Jonathan M Elkins, Panagis Filippakopoulos, et al.
Cell Death and Differentiation|July 26, 2018
TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1Loïc Lionnard, Pauline Duc, Margs S Brennan, et al.
Cancers|February 5, 2021
Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS OverproductionSofia Giacosa, Catherine Pillet, Irinka Séraudie, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|January 29, 2019
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding SiteBenoît Bestgen, Isabelle Krimm, Irina Kufareva, et al.
The Journal of Biological Chemistry|June 26, 2004
Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporterStein Roosbeek, Frank Peelman, Annick Verhee, et al.
Cancer Research|December 2, 2010
Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2Renaud Prudent, Virginie Moucadel, Chi-Hung Nguyen, et al.
Scientific Reports|November 6, 2019
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitorsIrina Kufareva, Benoit Bestgen, Paul Brear, et al.
Iscience|February 6, 2024
Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocketAlexandre Bancet, Rita Frem, Florian Jeanneret, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insightsMiriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Molecular and Cellular Biochemistry|June 20, 2008
Expanding the chemical diversity of CK2 inhibitorsRenaud Prudent, Virginie Moucadel, Miriam López-Ramos, et al.
Journal of Medicinal Chemistry|September 25, 2012
Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine BTania Tahtouh, Jonathan M Elkins, Panagis Filippakopoulos, et al.
Cell Death and Differentiation|July 26, 2018
TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1Loïc Lionnard, Pauline Duc, Margs S Brennan, et al.
Cancers|February 5, 2021
Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS OverproductionSofia Giacosa, Catherine Pillet, Irinka Séraudie, et al.
Pageof 7